VEGFR-3, VEGF-C and VEGF-D mRNA quantification by RT-PCR in different human cell types

Anticancer Research

Volumn 26, Issue 3 A, 2006, Pages 1885-1891

  Leclers, Dany ^a   Durand, Karine ^a   Cook Moreau, Jeanne ^a   Rabinovitch Chable, Hélène ^a   Sturtz, Franck G ^a   Rigaud, Michel ^a  

^a UNIVERSITY OF LIMOGES   (France)

Author keywords

Lymphangiogenesis; mRNA quantification; VEGF C; VEGF D; VEGFR 3

Indexed keywords

MESSENGER RNA; TUMOR MARKER; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

ARTICLE; CELL DIFFERENTIATION; CELL INVASION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SOLID TUMOR; T LYMPHOCYTE; TUMOR GROWTH;

CELL LINE, TUMOR; HUMANS; MELANOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 33745635737     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Karkkainen MJ and Alitalo K: Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis. Semin Cell Dev Biol 13: 9-18, 2002.
2. Aprelikova O, Pajusola K, Partanen J et al: FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter. Cancer Res 52: 746-748, 1992.
3. Karkkainen MJ and Petrova TV: Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 19: 5598-5605, 2000.
4. Paavonen K, Puolakkainen P, Jussila L et al: Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 156: 1499-1504, 2000.
5. Valtola R, Salven P, Heikkila P et al: VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 154: 1381-1390, 1999.
6. Partanen TA, Arola J, Saaristo A et al: VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J 14: 2087-2096, 2000.
7. Tanno S, Ohsaki Y, Nakanishi K et al: Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3. Lung Cancer 46: 11-19, 2004.
8. Witte D, Thomas A, Ali N et al: Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma. Anticancer Res 22: 1463-1466, 2002.
9. Li R, Younes M, Wheeler TM et al: Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate. Prostate 58: 193-199, 2004.
10. Longatto Filho A, Martins A, Costa SM et al: VEGFR-3 expression in breast cancer tissue is not restricted to lymphatic vessels. Pathol Res Pract 201: 93-99, 2005.
11. Fielder W, Graeven U, Ergun S et al: Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia. Leukemia 11: 1234-1237, 1997.
12. Achen MG, Jeltsch M, Kukk E et al: Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95: 548-553, 1998.
13. George ML, Tutton MG, Janssen F et al: VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. Neoplasia 3: 420-427, 2001.
14. Makinen T, Veikkola T, Mustjoki S et al: Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J 20: 4762-4773, 2001.
15. He Y, Kozaki K, Karpanen T et al: Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 94: 819-825, 2002.
16. Clarijs R, Schalkwijk L, Hofmann UB et al: Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma. Cancer Res 62: 7059-7065, 2002.
17. Dias S, Choy M, Alitalo K et al: Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy. Blood 99: 2179-2184, 2002.
18. Durand-Faucher K, Rabinovitch-Chable H, Dzugan H et al: A quantitative RT-PCR method to determine topoisomerase I mRNA levels in human tissue samples. Clin Chem Lab Med 43: 707-714, 2005.
19. Bustin SA and Nolan T: Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J Biomol Tech 15: 155-166, 2004.
20. de Kok JB, Roelofs RW, Giesendorf BA et al: Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab Invest 85: 154-159, 2005.
21. Hanrahan V, Currie MJ, Gunningham SP et al: The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. J Pathol 200: 183-194, 2003.
22. Schietroma C, Cianfarani F, Lacal PM et al: Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases. Cancer 98: 789-797, 2003.
23. Kawakami M, Furuhata T, Kimura Y et al: Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer. Surgery 133: 300-308, 2003.
24. Kitadai Y, Kodama M, Cho S et al: Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes. Int J Cancer 115: 388-392, 2005.
25. Onogawa S, Kitadai Y, Tanaka S et al: Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci 95: 32-39, 2004.
26. Wang JF, Ganju RK, Liu ZY et al: Signal transduction in human hematopoietic cells by vascular endothelial growth factor related protein, a novel ligand for the FLT4 receptor. Blood 90: 3507-3515, 1997.
27. Dias S, Hattori K, Zhu Z et al: Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest 106: 511-521, 2000.
28. Al-Rawi MA, Watkins G, Mansel RE et al: The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells. Int J Oncol 27: 721-730, 2005.
29. Fitzpatrick TE, Lash GE, Yanaihara A et al: Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor. Exp Cell Res 283: 247-255, 2003.